Physician profile
Howard Dash
NPI 1538117585
$543.45
in general payments reported to CMS, 2019-2025
10 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.60 · 2022: $24.65 · 2023: $75.54 · 2024: $239 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $260.48 | 2023-2025 | Stravix Pl, Collagenase Santyl, Grafix Pl |
| Tela Bio, INC. | $47.51 | 2020 | |
| Intuitive Surgical, INC. | $38.78 | 2024 | |
| Solventum Corporation | $36.14 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Becton, Dickinson and Company | $32.23 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $27.09 | 2020 | |
| Davol INC. | $26.34 | 2024 | Arista Ah Flexitip |
| Polynovo North America LLC | $25.17 | 2024 | Novosorb Btm |
| Eagle Pharmaceuticals, INC. | $25.06 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $24.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Dash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.